Simulation Makes Personalised Healthcare and 3D Printed Implants Possible | ANSYS Blog

We all understand that no two people are alike. However, when determining treatments, the medical profession tends to treat all patients based on an average body type. The truth is, personalised healthcare can help improve a patient’s chance of survival, recovery time and quality of life.

To that end, VOLMO, an ANSYS Startup Program member, has developed the ImageSim software. This medical software processes medical scans so that the geometry of 3D printed implants, stents and fixation plates can be digitally designed.

VOLMO then tests the geometry of the 3D printed implants in ANSYS Mechanical. Once these tests are complete, VOLMO prints the implants using additive manufacturing.

Instead of hoping for the best and preparing for the worst, medical practitioners can use ImageSim to plan treatments, practice surgeries and optimise patient recovery. This personalised healthcare strategy improves the ability of medical practitioners to get their patients back on their feet quickly and safely.

In Silico Trials, Via ANSYS Simulation, Enable Personalised Healthcare

A personalised pelvic implant is created using VOLMO’s ImageSim software. It is then tested using ANSYS Mechanical.

One of the benefits of VOLMO’s brand of personalised healthcare is that it can digitally test (in silico test) a patient’s treatment before surgery.

Instead of picking a treatment that was tested on clinical trials of selected patients, medical practitioners can design hundreds, perhaps thousands, of treatments that are simulated on the digital twin of the patient.

These in silico trials, using Mechanical simulations, will ensure that the 3D printed implants will not cause any stress or deformation under loading conditions that are specific to the patient.

Once these simulations are completed, VOLMO can print as many implants as it needs to perform physical tests if necessary. Once these final rounds of testing are completed, a final implant can be printed that is ready for surgery.

VOLMO’s in silico trials can expedite the approval processes of the U.S. Food and Drug Administration (FDA) and other regulatory bodies. Additionally, VOLMO’s technology can help close the door on one-size-fits-all medicine and make personalised healthcare a reality.

For more information about the ANSYS product range, please click here >>

Talk to one of our account managers for how ANSYS can benefit you, call now on 0161 474 6886.

This blog was originally posted on ANSYS’ website here.